Coen Stegeman Selected Research

Azathioprine (Imuran)

8/2013

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Coen Stegeman Research Topics

Disease

5	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 03/2010
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 08/2013 - 07/2010
2	Vasculitis (Vasculitides) 02/2012 - 05/2011
2	Microscopic Polyangiitis 03/2011 - 07/2010
1	COVID-19 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Glomerulonephritis 01/2017
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 01/2017
1	Body Weight (Weight, Body) 07/2010
1	Hemorrhage 07/2010

Drug/Important Bio-Agent (IBA)

4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2013 - 07/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 07/2010
2	AutoantibodiesIBA 01/2017 - 03/2012
2	AntibodiesIBA 01/2017 - 03/2011
2	Rituximab (Mabthera)FDA Link 08/2013 - 07/2010
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2017
1	Collagen Type VIIBA 01/2017
1	antiglomerular basement membrane antibodyIBA 01/2017
1	Azathioprine (Imuran)FDA LinkGeneric 08/2013
1	CreatinineIBA 02/2012
1	Prostaglandins AIBA 05/2011
1	GlucocorticoidsIBA 07/2010
1	Advanced Glycation End ProductsIBA 03/2010

Therapy/Procedure

3	Therapeutics 01/2017 - 07/2010
2	Remission Induction 08/2013 - 07/2010
1	Plasmapheresis 01/2017